B lymphocytes as therapeutic targets in systemic lupus erythematosus.

about

Autophagy, inflammation and neurodegenerative disease.The adaptor molecule Act1 regulates BAFF responsiveness and self-reactive B cell selection during transitional B cell maturation Elevated ATG5 expression in autoimmune demyelination and multiple sclerosis.

P2860

Q34686890-DF32D6C5-6F5F-4D95-9457-33D1F06EF7F7 Q35576420-F578707B-B177-4FDD-A3F7-7D5E468ABCC2 Q37426337-B67D49F5-1EDF-4517-9A99-8E5794B74048

P2860

B lymphocytes as therapeutic targets in systemic lupus erythematosus.

Item

http://www.wikidata.org/entity/Q36653646

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

B lymphocytes as therapeutic targets in systemic lupus erythematosus.

@ast

B lymphocytes as therapeutic targets in systemic lupus erythematosus.

@en

type

Item

label

B lymphocytes as therapeutic targets in systemic lupus erythematosus.

@ast

B lymphocytes as therapeutic targets in systemic lupus erythematosus.

@en

prefLabel

B lymphocytes as therapeutic targets in systemic lupus erythematosus.

@ast

B lymphocytes as therapeutic targets in systemic lupus erythematosus.

@en

P1476

B lymphocytes as therapeutic targets in systemic lupus erythematosus.

@en

P2093

Moncef Zouali

http://www.w3.org/2001/XMLSchema#string

Paul Hasler

http://www.w3.org/2001/XMLSchema#string

P2860

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

SLE--systemic lupus erythematosus: a BLySful, yet BAFFling, disorder

BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2

Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF

Hyperresponsive B cells in CD22-deficient mice

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

The epitope recognized by rituximab.

Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes.

P304

803-815

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.10.6.803

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17105369

http://www.w3.org/2001/XMLSchema#string

B lymphocytes as therapeutic targets in systemic lupus erythematosus.

about

P2860

P2860

B lymphocytes as therapeutic targets in systemic lupus erythematosus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698